A growing body of research suggests that loss of the retinoblastoma tumor suppressor gene (Rb), leads to accelerated angiogenesis and tumor progression which is one of the most important biomarkers associated with acquired resistance and lower PFS to CDK4/6i32,33. The gene discussed is RB1; the disease is neoplasm.